Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
STIMULAN VG
- Development stage
- Phase 2
- Lead developer
- Biocomposites
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Surgical Implantation
01
Overview
STIMULAN VG is a drug-device combination consisting of a fully synthetic, absorbable calcium sulfate matrix pre-mixed with the antibiotics vancomycin and gentamicin. It is designed as a local antibiotic delivery system for use in bone and soft tissue infection management. The product acts as an antibiotic carrier, delivering high concentrations of vancomycin (a glycopeptide) and gentamicin (an aminoglycoside) directly to the site of infection, such as musculoskeletal defects or wounds associated with diabetic foot osteomyelitis or stage IV pressure ulcers. The calcium sulfate matrix gradually dissolves over 30–60 days, releasing the antibiotics locally while minimizing systemic exposure. This approach aims to improve infection control, reduce recurrence rates, and minimize systemic antibiotic use[2][3][4].
- Brand names
- STIMULAN VG
- Other names
- calcium sulfate with vancomycin and gentamicin
02
Targets
30S A-site (Bacterial ribosomal 30S A-site)D-Ala-D-Ala (D-Ala-D-Ala terminus)
Beyond the preview
Go deeper on STIMULAN VG.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on STIMULAN VG.